MISSION

Contribute to health and fruitful living with
our knowledge and technologies

NEWS

BUSINESS

  • Development of medicines, healthy foods, and cosmetic materials with natural resources

  • Natural resources and products

  • Databases of medicinal plants and extracts for drug discovery

  • Cultivation methods for medicinal plants, culture technology for microorganisms

  • Equipment and systems for R&D

  • Evaluation of drug efficacy

  • Consulting for pharmaceutical development consulting and medical writing (CMC)

RESEARCH and DEVELOPMENT

There are approximately 30,000 traditional medicinal plants on the earth, and approximately 80% of the world's population is still using them. In addition, medicinal plants of which use and active ingredients have not been well investigated, and marine resources and microorganisms that have not been utilized yet are abundant in nature.
Kumamoto Pharma Co., Ltd., in cooperation with the School of Pharmacy, Kumamoto University, contributes to improving the lives of patients by developing traditional medicines and drug discovery inspired by medicinal plants, marine resources and microorganisms.

ABOUT US

Member

  • CEO
    Nobusuke NISHI
    Ph.D
    西 信介
    Career
    1987
    Kirin Brewery Co., Ltd. Pharmaceutical Division (current Kyowa Kirin Co., Ltd.)
    2009
    Novartis Pharma KK Japan Program Head
    2014
    REGiMMUNE Corporation Head of Research & Development
    2017
    Gene Techno Science Co., Ltd. Head of Pharmaceutical Products
    2019 -
    Visiting professor, Kumamoto University
  • Head of Business Development, board member
    Akinori HISATSUNE
    Ph.D
    久恒 昭哲
    Career
    2000
    Hisamitsu Pharmaceutical Co., Inc.
    2002
    Kumamoto University, School of Pharmacy
    (2002 to 2004 University of Maryland)
    2013
    Associate professor of Kumamoto University
    2019 -
    Visiting professor, Kumamoto University
  • Outside board member
    Keima UENO
    Career

    CEO of Dojin Group Co., Ltd.

  • Company auditor
    Masahiko TANAKA
    田中 正比古
    Career
    1974
    The Chemo-Sero-Therapeutic Research Institute
    2007
    Tokyo CRO Co., Ltd.
    2010
    The Chemo-Sero-Therapeutic Research Institute
    2012
    Daigenkai Tanoue Hospital

Company

Name
Kumamoto Pharma Co., Ltd.
Establish
April 1, 2019
Capital fund
6 million yen
Board members
CEO
Nobusuke NISHI
Head of BD
Akinori HISATSNE
Outside board member
Keima UENO
Company auditor
Masahiko TANAKA

CONTACT

If you have any questions or comments,
please use the form below.

PAGE TOP